Bullish
Cencora Inc. has appointed its former CEO, Steven Collis, as the new chair of the board shortly after his departure as chief executive. This leadershi...
Neutral
Cencora Inc. has updated its fiscal year 2026 financial outlook, modestly raising its adjusted earnings guidance and authorizing an additional $2 bill...
Bullish
Cencora, formerly AmerisourceBergen, is undergoing a strategic transformation with solid earnings and guidance, maintaining its position as a key phar...
Bearish
Cencora (US15135B1017) faced a Q2 2026 revenue miss, reduced guidance, and a significant stock drop, leading to a shareholder investigation. The compa...
Bullish
Latitude Investment Management's Q4 2025 investor letter highlights Cencora (NYSE: COR) as a strong performer, driven by robust fundamentals and a str...
Neutral
Wells Fargo maintained its Overweight rating on Cencora (COR) but lowered its price target to $331 from $429 due to disappointing U.S. healthcare earn...
Neutral
Cencora reported Q2 fiscal 2026 results that missed analyst expectations, with revenue of $78.36 billion falling short of the $81.09 billion consensus...
Cencora (NYSE:COR) is set to trade ex-dividend soon, offering a US$0.60 per share dividend with a trailing yield of 0.9%. The company exhibits strong ...
Cencora's stock (COR) has recently experienced weakness, but long-term performance remains strong. A Discounted Cash Flow (DCF) analysis suggests the ...
Bullish
Artemis Investment Management LLP significantly increased its stake in Cencora, Inc. (NYSE:COR) by 54.4% in the fourth quarter, acquiring an additiona...
Neutral
Vanguard Capital Management has revealed a 7.3% stake in Cencora (NYSE:COR), held for investment purposes, classifying them as one of the largest inst...
Bullish
Axecap Investments LLC significantly increased its stake in Cencora, Inc. (NYSE:COR) by 114.0% in Q4, adding 3,428 shares to reach a total of 6,434 sh...